Results 221 to 230 of about 48,951 (258)

IVERMECTIN FOR ONCHOCERCIASIS

The Lancet, 1982
openaire   +2 more sources

Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results

Journal of Clinical Epidemiology, 2022
Ariel Izcovich, Tortosa Fernando, Martin Alberto Ragusa   +2 more
exaly  

Ivermectin for Scabies

Journal of Paediatrics and Child Health, 2003
openaire   +2 more sources

Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study

International Immunopharmacology, 2021
Kawkab A Ahmed, Azza Mahmoud
exaly  

Ivermectin

Reactions Weekly, 2018
openaire   +2 more sources

Development of microemulsion based topical ivermectin formulations: Pre-formulation and formulation studies

Colloids and Surfaces B: Biointerfaces, 2020
Pui Shan Chow, Sie Huey Lee
exaly  

Flawed ivermectin preprint highlights challenges of COVID drug studies

Nature, 2021
S. Reardon
semanticscholar   +1 more source

Ivermectin

Reactions Weekly, 1991
openaire   +1 more source

Evaluation of the efficacy of oral ivermectin in comparison with ivermectin–metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum

International Journal of Infectious Diseases, 2013
Nairmen Nabih
exaly  

Ivermectin: panacea for resource-poor communities?

Trends in Parasitology, 2014
Andy Crump
exaly